Eversana Buys Waltz Health to Make $6B Firm to Upend US Drug Middlemen
🎧 Listen to AI Summary
From bloomberg.com: Did you know that a $6 billion company is shaking up the way we buy medications in the U.S.? Eversana, a powerhouse in helping drugmakers market their medicines, just acquired Waltz Health, a nimble firm that aids employers and insurers in finding cheaper drug options. This merger aims to create a compelling alternative to traditional pharmacy benefit managers, who often complicate the purchasing process. But why is this important? With rising drug costs impacting millions, Eversana's move could streamline access to affordable medications. Mark Thierer, the new leader of this combined entity, hints at a transformative approach, though he keeps the acquisition price under wraps. As the healthcare landscape evolves, this partnership highlights a growing trend: the push for transparency and cost-effectiveness in drug purchasing. Will this new model reshape the industry? Learn more about this at bloomberg.com.
Full Article
Read Original →Eversana, a company that helps drugmakers sell their medicines, has acquired a smaller firm called Waltz Health that helps employers and health insurance companies purchase cheaper drugs, in a bid to build an alternative to traditional pharmacy benefits middlemen in the US.The combined company, which will remain closely held, is valued at $6 billion, according to Mark Thierer, who will lead it, though he declined to say what Eversana paid for Waltz.